Fred Koehl Shares the Lessons from His Cholangiocarcinoma Diagnosis, Awaiting a Treatment to "Beat This Thing"

August 2020, Vol 1, No 1

Fred Koehl, who spoke at the 2020 Cholangiocarcinoma Foundation (CCF) Annual Conference, was a 62-year-old healthy man living in Atlanta, GA, who was “not ready to go” when he was diagnosed with extrahepatic cholangiocarcinoma (CCA) 7 years ago. Mr Koehl’s disease was diagnosed at an early stage (stage I), and after surgery to remove the tumor (including part of his pancreas), radiation, and 12 cycles of gemcitabine and cisplatin therapy, he was told he had “no evidence of disease.”

That continued until early 2017, when he had a recurrence of CCA. More chemotherapy and a surgical procedure to remove a tumor became Mr Koehl’s new reality. He is currently receiving treatment in a clinical trial, and his best hopes at this stage of his life are disease stability, if not tumor shrinkage, and staying in the clinical trial.

As of the CCF conference, Mr Koehl’s disease is stable, but his CA19-9 level continues to rise, and 2 suspicious areas were noted on a recent scan. “My objective is to keep kicking the can down the road until a treatment is found so that I can beat this thing,” he told the audience.

5 Tips for Patients with CCA

Mr Koehl’s advice to other patients with CCA is meant primarily for men and women who were newly diagnosed with this type of cancer, but it is relevant to all patients with this disease.

“I cannot get rid of your cancer any more than I can get rid of mine, but maybe I can provide some thoughts about how to make the journey a bit less scary, and maybe have you think of some ways to deal with all of this stuff a little better,” Mr Koehl said. He discussed the following 5 major themes that he has used as a guide in his experience with cancer.

  1. Seek knowledge to be empoweredKnow that there are many resources being expended today with the goal of treating and ultimately beating CCA. Knowledge is empowering. Be an informed patient, not a victim.
  2. Explore and act on your optionsGenomic testing is widely available these days. Get tested! Genetic mutations do matter. Some of the best treatment success stories started with genomic testing. Get the best medical team that you can. Push hard to get the best treatment available. The CCF can help with your search. And take good care of yourself. Live your life in the healthiest way possible. Good lifestyle choices can help improve the likelihood of your success in this battle.
  3. Make plans and live your lifeIn many ways, this is easier said than done, but don’t sit back and say, “woe is me.” None of us is promised tomorrow, so have short- and long-term life goals and objectives.
  4. Be physically activePhysical activity can help during cancer treatment and recovery. Don’t let a physical limitation prevent you from maintaining an active lifestyle. Do something every day, and then a little bit more tomorrow.
  5. You are not aloneSupport cannot cure CCA, but it can certainly make your experience better. Knowledge, concern, and care are things that can come from other patients with CCA and our caregivers.

“All of us can gain from the support of one another. Be open to sharing and gaining the benefit of what we all can offer one another,” Mr Koehl concluded.

Related Items

Importance of Proper Nutrition in Patients With Cholangiocarcinoma
June 2023, Vol 4, No 2
A specialist in oncology nutrition and the caregiver of a patient with cholangiocarcinoma discuss the importance of proper nutrition in achieving positive cancer outcomes.
Physician Debate: Is Chemotherapy Still the Backbone for CCA Treatment?
June 2023, Vol 4, No 2
Dr Rachna Shroff and Dr Madhulika Eluri debated whether it is time to move away from chemotherapy as a mainstay in the treatment of cholangiocarcinoma.
Incorporating ctDNA Into Clinical Trial Design
June 2023, Vol 4, No 2
Cholangiocarcinoma experts discussed potential applications of liquid biopsies using circulating tumor DNA.
Harnessing the Microbiome to Optimize Response to Immunotherapy
June 2023, Vol 4, No 2
Dr Marina Barcena-Varela described a study that aims to understand how the microbiome affects cholangiocarcinoma tumorigenesis based on genetic alterations and response to targeted and immunotherapy.
New Treatment Strategy for FGFR2 Fusion–Positive CCA
June 2023, Vol 4, No 2
Dr Michael E. Lidsky described a novel investigative murine model of FGFR2 fusion–positive intrahepatic cholangiocarcinoma and how it may enhance treatment outcomes.
CDX-1140 Plus Capecitabine, Oxaliplatin, and Pembrolizumab in Advanced BTC
June 2023, Vol 4, No 2
Dr Cecilia Monge presented the rationale and study design for a new phase 2 study investigating the CD40 agonist CDX-1140 in combination with capecitabine, oxaliplatin, and pembrolizumab in advanced biliary tract cancer.
Emerging Therapeutic Targets for CCA From Translational Research
June 2023, Vol 4, No 2
Dr Tim F. Greten discussed emerging targets for the treatment of cholangiocarcinoma coming from translational research studies.
Advances in CAR T-Cell Therapy in CCA
June 2023, Vol 4, No 2
Dr Mark O’Hara discussed the growing potential of CAR T-cell therapy in cholangiocarcinoma.
The Future of Clinical Trial Design in CCA Informed by Past Experiences
June 2023, Vol 4, No 2
Dr Sandra J. Casak discussed future thinking regarding clinical trials in cholangiocarcinoma, including a “seamless” oncology drug development paradigm.
Hot Topics on Cholangiocarcinoma at the 2023 Cholangiocarcinoma Foundation Annual Conference
By Melinda Bachini; Juan W. Valle, MB ChB, MSc, FRCP
Videos
On April 14, 2023, we presented an overview of key abstracts on cholangiocarcinoma (CCA) presented at the 2023 Cholangiocarcinoma Foundation Annual Conference.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: